BLA Regulatory

BLA Regulatory

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

BLA Regulatory is a Boston-based, private regulatory affairs consultancy serving biotech and pharma companies globally. It leverages a team with over 130 years of combined experience, including former FDA personnel, to provide services ranging from gap analysis and health authority meetings to full application submission and clinical trial registration. The firm has a proven track record, having assisted with over 300 INDs and 50 marketing applications, and was recognized as a Top 10 Emerging Consulting Company in 2022. Its business model is entirely service-based, generating revenue through client consulting engagements.

Regulatory AffairsDrug Development

Technology Platform

Integrated regulatory affairs service model leveraging a team with combined experience from FDA and industry. Services include gap analysis, health authority meetings, IND/BLA/NDA filing, clinical trial registration, medical writing, and eCTD publishing.

Opportunities

Growing demand for outsourced regulatory expertise from virtual and small biotech companies.
Expansion into guiding complex therapies (cell/gene, combination products) and expedited regulatory pathways (Fast Track, Breakthrough Therapy).
Increasing globalization of drug development creates need for multi-regional regulatory strategy.

Risk Factors

High competition from large CROs and other boutique consultancies.
Revenue dependency on the funding cycle and pipeline success of biotech clients.
Key personnel risk, as value is tied to individual consultants' expertise and reputations.

Competitive Landscape

Competes with large, full-service Contract Research Organizations (CROs) that have regulatory divisions, as well as other specialized regulatory affairs consulting boutiques. Differentiation is based on niche expertise, particularly former FDA regulator experience, personalized service, and a proven track record with INDs and marketing applications.